Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
*The evidence report provides details of the search strategies (7).

Figure 1. Study flow diagram.
The reasons for exclusion exceed the total number of studies because reviewers could enter multiple reasons for exclusion.
89 studies were not included in this review because they included children or infants only or examined barriers only. Toxicity and efficacy studies in sickle cell disease overlap.
Return to article